Literature DB >> 19697587

Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study.

Ljudmila Stojanovich1, Dusica Smiljanich-Miljkovich, Roald Omdal, Boris Sakic.   

Abstract

BACKGROUND: Recent experimental evidence points to brain-reactive antibodies as a key factor in the pathogenesis of neuropsychiatric systemic lupus erythematosus (central nervous system-SLE). However, clinical studies in which circulating (serum) autoantibodies were correlated with neuropsychiatric manifestations have not produced consistent findings.
OBJECTIVES: To test the hypothesis that autoantibodies in cerebrospinal fluid are more reflective of functional brain damage.
METHODS: We compared the behavioral profiles of 12 NP-SLE patients, some of whom had immunoglobulin G in their CSF.
RESULTS: Western blotting revealed heavy and light chain IgG bands in six patients similar in age to the subgroup of CSF IgG-free patients. A series of serological measures did not differ between the subgroups, but SLEDAI scores and daily steroid doses were higher in patients with IgG in their CSF. All three patients with severe deficits in verbal and executive functions were positive for the CSF IgG, while three other patients with psychosis were CSF IgG-negative.
CONCLUSIONS: Although the present sample size is relatively small, the results support the relationship between disease severity and central manifestations of autoimmunity. They also emphasize the importance of clinical studies that compare subpopulations of NP-SLE patients and justify development of animal models in which controlled immune mechanisms induce specific deficits in behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697587      PMCID: PMC2894080     

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  23 in total

1.  Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations.

Authors:  N S Lai; J L Lan
Journal:  Lupus       Date:  2000       Impact factor: 2.911

2.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.

Authors:  L A DeGiorgio; K N Konstantinov; S C Lee; J A Hardin; B T Volpe; B Diamond
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

3.  Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: correlation with central nervous system involvement.

Authors:  G W Williams; H G Bluestein; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1981-01

4.  Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study).

Authors:  L Stojanovich; R Stojanovich; V Kostich; E Dzjolich
Journal:  Lupus       Date:  2003       Impact factor: 2.911

5.  Altered CNS response to injury in the MRL/MpJ mouse.

Authors:  D W Hampton; A Seitz; P Chen; E Heber-Katz; J W Fawcett
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 6.  Genetic basis of murine lupus.

Authors:  Marie-Laure Santiago-Raber; Catherine Laporte; Luc Reininger; Shozo Izui
Journal:  Autoimmun Rev       Date:  2004-01       Impact factor: 9.754

7.  Antibodies reactive with central nervous system antigens.

Authors:  H G Bluestein; N J Zvaifler
Journal:  Hum Pathol       Date:  1983-05       Impact factor: 3.466

Review 8.  The blood-brain barrier in systemic lupus erythematosus.

Authors:  N J Abbott; L L F Mendonça; D E M Dolman
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  Neuronal antibodies and cognitive function in systemic lupus erythematosus.

Authors:  J A Denburg; R M Carbotte; S D Denburg
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

10.  Cognition and immunity; antibody impairs memory.

Authors:  Czeslawa Kowal; Lorraine A DeGiorgio; Tsukasa Nakaoka; Hoby Hetherington; Patricio T Huerta; Betty Diamond; Bruce T Volpe
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

View more
  5 in total

Review 1.  Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.

Authors:  Aida Zarfeshani; Kaitlin R Carroll; Bruce T Volpe; Betty Diamond
Journal:  Curr Rheumatol Rep       Date:  2021-03-29       Impact factor: 4.592

2.  Neuropsychiatric Symptoms in Lupus.

Authors:  Maria Gulinello; Jing Wen; Chaim Putterman
Journal:  Psychiatr Ann       Date:  2012-09

3.  Higher IgG level correlated with vitamin D receptor in the hippocampus of a pristane-induced lupus model.

Authors:  Thaís Evelyn Karnopp; Eduarda Correa Freitas; Alexandre Rieger; Gustavo Flores Chapacais; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2022-02-12       Impact factor: 2.980

4.  Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study.

Authors:  L Langensee; J Mårtensson; A Jönsen; K Zervides; A Bengtsson; J Nystedt; B Cannerfelt; P Nilsson; P Mannfolk; J Lätt; T Rumetshofer; P C Sundgren
Journal:  BMC Rheumatol       Date:  2022-04-20

5.  Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.

Authors:  Minesh Kapadia; Dunja Bijelić; Hui Zhao; Donglai Ma; Ljudmila Stojanovich; Milena Milošević; Pavle Andjus; Boris Šakić
Journal:  Acta Neuropathol Commun       Date:  2017-09-07       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.